ICCM (IceCure Medical, Ltd.) Company Projected Revenue

Brandmark of icecure-medical.com (ICCM)

The development of IceCure Medical Ltd (ICCM) relies on the expansion of regulatory approvals for cryogenic systems, while unique patents mitigate risks. Planned sales revenues help filter out management noise to reveal real demand, where 0.00 serves as the baseline parameter value. High promotion costs for cryoablation create an operating deficit, and the business's success depends on insurance reimbursements and the adoption of the method in oncology.

ICCM - IceCure Medical Ltd Company Expected Sales Volume over the range 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company IceCure Medical Ltd (ICCM)

- current price and projected stock value:
Fundamental company analysis:IceCure Medical Ltd.
Brand item of IceCure Medical, Ltd.

For IceCure Medical Ltd (ICCM), this indicator serves as a market noise filter, separating speculative demand from genuine growth potential. The analysis of financial sales expectations is based on forecasting future cash flows from product sales. For the company, this implies a correlation between the implementation of ProSense systems and the sales volume of disposable probes. Local dips in the curve may indicate a temporary undervaluation of the asset. Investors should utilize this trend to determine entry points for long-term planning.

Analysis of competing companies

Company Future Sales Volume DXCM (Dexcom)|Company Future Sales Volume Penumbra PEN|Company Projected Revenue Novanta Photonics NOVT|Haemonetics Corp. (HAE) - Company Expected Sales Volume|Inspire Medical - Projected Sales Volume|Company Expected Sales Volume PROCEPT BioRobotics|CNMD: Projected Sales Volume|Company Revenue Forecast PLSE|INMD (InMode MD) - Projected Sales Volume|Company Future Sales Volume Picard Medical Inc. (PMI)|Projected Sales Volume SRDX|Company Future Sales Volume Senseonics Holdings SENS|Projected Sales Volume NPCE (neuropace.com)|Projected Sales Volume Tactile Systems Technology TCMD|SNWV - Company Projected Revenue|Company Expected Sales Volume Outset Medical Corp|ELMD (Electromed Inc) - Company Future Sales Volume|LENSAR, Inc. - Company Future Revenue|RCEL (AVITA Medical Inc) - Projected Sales Volume|Company Expected Sales Volume profoundmedical.com PROF|Company Projected Revenue Baird Medical (BDMD)|EDAP Medical (EDAP) - Company Sales Forecast|Apyx Medical Corp - Company Future Sales Volume|Projected Sales Volume Pulmonx Corp. LUNG|TELA Bio Inc. - Projected Sales Volume|Company Future Sales CytoSorbents Corporation CTSO|Sensus Healthcare (SRTS) - Company Projected Revenue|Company Expected Revenue ZYXI (Zynex Corp)|Company Projected Revenue electrocore.com|Company Future Sales Volume Vicarious Surgical Inc. (RBOT)|Projected Sales Volume IINN|SeaStar Medical Holding Corp - Company Revenue Forecast|Company Projected Revenue iridex.com IRIX|INBS: Company Revenue Forecast|XAIR: Company Future Sales Volume|profusa.com - Company Projected Revenue Volume|STRATA Skin Sciences (SSKN) - Company Projected Revenue|Company Sales Forecast glucotrack.com GCTK|NAOV (nanovibronix.com) - Projected Sales Volume|Company Expected Sales Volume Venus Concept Corporation VERO|Company Future Sales Volume NUWE (nuwellis.com)|Company Projected Revenue Volume AEMD|Company Projected Revenue asensus.com ASXC|AVGR: Company Revenue Forecast|BioSig Technologies, Inc - Projected Sales Volume|Company Future Revenue CUTR (Cutera, Inc)|KNW: Projected Sales Volume|inarimedical.com - Company Future Revenue|NVRO (Nevro Corp) - Projected Sales Volume|Company Expected Sales Volume ReShape Lifesciences Inc. RSLS|Projected Sales Volume SILK